
The Gujarat Kidney and Super Speciality IPO enters its second day of subscription today, 23 December 2025. By the end of the first day, the issue was subscribed to 1.54 times overall. The bidding window is scheduled to close on December 24, 2025.
Issue Type: The Gujarat Kidney and Super Speciality IPO is a book-building issue of ₹250.80 crore, consisting entirely of a fresh issue of 2.20 crore shares.
Price Band: The price band is set between ₹108 and ₹114 per share.
Lot Size & Minimum Investment: The lot size for an application is 128 shares, and the minimum investment required is ₹14,592 (for retail investors).
Allotment Date: The basis of allotment will be finalised by December 26, 2025
Listing Date: The tentative listing date on NSE and BSE is December 30, 2025.
Book-running Lead Managers: Nirbhay Capital Services Private Limited
Registrar: MUFG InTime India Pvt. Ltd.
[23-December-2025 11:33:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.34 |
|
Non-Institutional Investors |
2.33 |
|
Retail Individual Investors (RIIs) |
7.53 |
|
Total |
2.03 |
[22-December-2025 17:00:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.34 |
|
Non-Institutional Investors |
1.98 |
|
Retail Individual Investors (RIIs) |
5.07 |
|
Total |
1.54 |
The net proceeds from the fresh issue will be used towards the following objectives:
Explore other Upcoming IPOs on BSE and NSE.
According to media reports, the Grey Market Premium (GMP) of the Gujarat Kidney and Super Speciality IPO is reported at ₹4 over the IPO price.
Gujarat Kidney and Super Speciality Hospital is a super speciality healthcare facility located in Vadodara, Gujarat. The hospital provides a comprehensive range of medical and surgical services, with core expertise in nephrology, urology, renal transplantation, and other high-end specialities. In addition, it offers treatment across general medicine and surgery, cardiology, neurology, oncology, gastroenterology, orthopaedics, and other allied disciplines.
Check out newly Listed IPOs on BSE and NSE.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.